MeridianConsensus
Operator profileZTSUnited StatesData as of June 2026

Zoetis

Zoetis is American animal health company. Founded in 1952. (Wikidata)

Zoetis's strongest tracked position is the Pet Pathogen Detection Kits Market at an estimated 16.0% share in a market growing at 6.8% CAGR. Average estimated share across all tracked markets is 19.0%, indicating a concentrated leadership position.

Meridian Consensus tracks Zoetis in 2 markets across 2 industries (healthcare, Healthcare). Estimated in-market revenue is $701M, the sum of share × market size across appearances — a modeled figure, not reported company revenue.

Filed financials · SEC 10-K · FY2025

EDGAR · CIK 1555280
Revenue (filed)
$9.5B
Net income (filed)
$2.7B
Total assets (filed)
$15.5B

Exchange-filed figures from SEC XBRL companyfacts (Zoetis Inc.). The modeled in-market estimates below cover only the markets Meridian tracks and will not sum to filed revenue.

Markets tracked
2
Industries
2
Est. in-market revenue
$701M
Top market share
16.0%

Share and revenue figures are Meridian model estimates reconciled through the publish-gate validator, not audited financials. Methodology

Market positions

Avg share 19.0% · sorted by est. revenue
MarketCAGRShare
Pet Pathogen Detection Kits Market6.8%16.0%
Veterinary Urinalysis Market5.0%22.0%
Est. revenue by market (share × market size)
Pet Pathogen Detection Kits$459M
Veterinary Urinalysis$242M

Meridian Dossier

Need diligence-grade depth on Zoetis?

Commission a source-cited diligence dossier on Zoetis: identity, filed financials, IP, litigation, and government exposure. Free preview first, from $299.

Zoetis: frequently asked

Meridian Consensus tracks Zoetis in 2 markets: Pet Pathogen Detection Kits Market ($2.9B), Veterinary Urinalysis Market ($1.1B), spanning healthcare, Healthcare.

Zoetis's strongest tracked position is the Pet Pathogen Detection Kits Market, a $2.9B market growing at 6.8% CAGR, where it holds an estimated 16.0% share as of June 2026.

Across Meridian-tracked markets, Zoetis's closest peers are IDEXX Laboratories, Antech Diagnostics, Virbac, Neogen Corporation, bioMérieux, with the largest overlap in the Pet Pathogen Detection Kits Market. Peer mapping is based on co-appearance in the same tracked markets.

No. Share and revenue figures on this page are model estimates produced by Meridian's research pipeline and committee-reviewed before publication; they are not audited or exchange-filed financials. Market-level sizings are reconciled against external sources during the publish gate.

Adjacent markets in healthcare · Healthcare

Tracked markets in the same industries where Zoetis is not among the named operators. Each carries Porter Five Forces, SWOT, country analysis, and a full competitor table.

Operators that compete with Zoetis

Meridian Consensus Digest

Free · Weekly

Not ready to commission a full report? Get our weekly briefing instead: new market sizings, thesis revisions, and reconciliation updates. Signed by the research team. No sales emails.

Subscribed by teams in Corporate Development, PE, and Management Consulting. Unsubscribe in one click.